Prevention of Dopamine-Induced Cell Death by Thiol Antioxidants: Possible Implications for Treatment of Parkinson's Disease

Author： Offen D. Ziv I. Sternin H. Melamed E. Hochman A.

Publisher： Elsevier

ISSN： 0014-4886

Source： Experimental Neurology, Vol.141, Iss.1, 1996-09, pp. : 32-39

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mechanisms of Dopamine-Induced Cell Death in Cultured Rat Forebrain Neurons: Interactions with and Differences from Glutamate-Induced Cell Death

By Hoyt K.R. Reynolds I.J. Hastings T.G.

Experimental Neurology, Vol. 143, Iss. 2, 1997-02 ,pp. : 269-281

Elsevier

Access to resources Recommend Favorite

Dopamine Cell Degeneration Induced by Intraventricular Administration of 6-Hydroxydopamine in the Rat: Similarities with Cell Loss in Parkinson's Disease

By Rodrguez M. Barroso-Chinea P. Abdala P. Obeso J. Gonzalez-Hernandez T.

Experimental Neurology, Vol. 169, Iss. 1, 2001-05 ,pp. : 163-181

Elsevier

Access to resources Recommend Favorite

Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias

By de la Fuente-Fernández Raúl Sossi Vesna Huang Zhigao Furtado Sarah Lu Jian-Qiang Calne Donald B. Ruth Thomas J. Stoessl A. Jon

Brain, Vol. 127, Iss. 12, 2004-12 ,pp. : 2747-2754

Oxford University Press

Access to resources Recommend Favorite

Neuronal cell death in Huntington's disease: a potential role for dopamine

By Jakel R.J. Maragos W.F.

Trends in Neurosciences, Vol. 23, Iss. 6, 2000-06 ,pp. : 239-245

Elsevier

Access to resources Recommend Favorite

Endogenous dopamine release in Parkinson's disease

By Rinne J.O.

Lancet Neurology, Vol. 2, Iss. 8, 2003-08 ,pp. : 460-461

Elsevier

Access to resources Recommend Favorite